← Open Payments lookup

KELLY LOHMANN: Open Payments

NPI 1417275629 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$31,199 in 150 payments from 12 companies in 2025. Trend: 2023 $11,323 · 2024 $24,719 · 2025 $31,199

Speaker / faculty: $21,970Consulting: $3,820Food & beverage: $3,244Travel & lodging: $2,165
CompanyPaymentsAmount
Alkermes, Inc.56$23,367
ABBVIE INC.37$6,252
Otsuka America Pharmaceutical, Inc.13$296
Neurocrine BioSciences, Inc.9$267
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$244
Vanda Pharmaceuticals Inc.3$172
E.R. Squibb & Sons, L.L.C.8$155
Janssen Scientific Affairs, LLC1$125
Axsome Therapeutics, Inc.4$94
Lundbeck LLC5$91

Products named: LYBALVI, VRAYLAR, ARISTADA, INGREZZA, CAPLYTA, INVEGA SUSTENNA, COBENFY, FANAPT.

Industry payments across MD — which companies pay providers there.